TENOFOVIR ALAFENAMIDE FUMARATE IS EFFECTIVE AND HAS SUPERIOR RENAL SAFETY MAINLY AMONG STAGE 2 CHRONIC KIDNEY DISEASE (CKD): REAL-WORLD STUDY FROM THE CANADIAN HEPATITIS B NETWORK (CANHEPB)

TitleTENOFOVIR ALAFENAMIDE FUMARATE IS EFFECTIVE AND HAS SUPERIOR RENAL SAFETY MAINLY AMONG STAGE 2 CHRONIC KIDNEY DISEASE (CKD): REAL-WORLD STUDY FROM THE CANADIAN HEPATITIS B NETWORK (CANHEPB)
Publication TypeConference Paper
Year of Publication2019
AuthorsFarag, M. S., S. K. Fung, E. Tam, K. E. Doucette, A. Wong, A. Ramji, B. Conway, C. Cooper, K. Tsoi, C. S. Coffin, and others
Conference NameHEPATOLOGY
PublisherWILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA